Latest Actinic keratosis Stories
SAN DIEGO, Oct. 8 /PRNewswire-FirstCall/ -- Nventa Biopharmaceuticals Corporation (TSX: NVN), a company developing innovative therapeutics for the treatment of viral infections and cancer, today provided an update on its ongoing development programs.
SAN DIEGO, Oct. 8 /PRNewswire-FirstCall/ -- Nventa Biopharmaceuticals Corporation (TSX: NVN) today presented positive data from preclinical studies using its proprietary Toll-like Receptor 3 agonist, Poly IC-Poly Arginine (Poly-ICR), at the World Vaccine Congress 2008 in Lyon, France.
To: MEDICAL EDITORS Contact: Gisele Galoustian of Florida Atlantic University, +1- 561-297-2010, email@example.com BOCA RATON, Fla., Sept. 5 /PRNewswire-USNewswire/ -- The Florida Technology, Research and Scholarship Board recently awarded Florida Atlantic University researcher Dr.
By Lee Tolliver, The Virginian-Pilot, Norfolk, Va. Jul. 28--Gone are the unsightly scabs. Left behind are small pink circles, bright and obvious against tanned skin -- signs of a new beginning.
Valeant Pharmaceuticals (NYSE:VRX) today announced that Spear Pharmaceuticals has agreed not to market, sell or ship a generic fluorouracil cream 5% pursuant to a stay in Valeant's legal case against the Food and Drug Administration (FDA).
By Megan Rauscher NEW YORK (Reuters Health) - Regular, long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) may protect against the development of actinic keratosis, a precancerous skin condition caused by long-term exposure to the sun, and squamous cell cancers (SCC) of the skin, according to a study conducted in subtropical Queensland, Australia.
- The act of sweetening by admixture of some saccharine substance.